Large R&D centric businesses have a huge asset in the vast experience that exists in their leading scientists – every trick in the book should
Pharmaceutical R&D is a complex, long and expensive task with a high project attrition rate. Only 5% of drug projects, that reach the stage of
A good understanding of the R&D pipeline and portfolio is essential to reduce waste, duplication and poor use of valuable resources, says Joe de Sousa
R&D Today officially launched at R&D Management Conference 2016; community website aims to be ‘trip advisor’ of best practice.
R&D Management Conference includes many sessions of interest to practitioners including keynotes by Warren East of Rolls-Royce plc, Joe de Sousa AstraZeneca, David Teece